...
首页> 外文期刊>Journal of radiation research >Simulational study of a dosimetric comparison between a Gamma Knife treatment plan and an intensity-modulated radiotherapy plan for skull base tumors
【24h】

Simulational study of a dosimetric comparison between a Gamma Knife treatment plan and an intensity-modulated radiotherapy plan for skull base tumors

机译:伽玛刀治疗计划和调强放疗计划治疗颅底肿瘤的剂量学比较的模拟研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We treated 14 patients with a skull base (n = 5) or cavernous sinus (n = 4) meningioma, craniopharyngioma (n = 4), or pituitary adenoma (n = 1) by intensity-modulated stereotactic radiotherapy (IM-SRT) using Novalis from April 2011 through June 2012. In this study, a GK PFX treatment plan was additionally made as a simulation plan for each patient. Actual treatment plans using Novalis and simulation plans of GK PFX were compared. The treatment-planning images were acquired with magnetic resonance imaging (MRI) using a 1.5-Tesla or 3.0-Tesla scanner (Signa Echo Speed Plus 1.5 T, Signa HDxt 3.0 T; GE Healthcare, Tokyo) and 4-detector computed tomography (CT) (Light Speed Plus; GE Healthcare, Tokyo). The references for dose calculation in treatment planning were the CT images. A CT image resolution of 512 × 512 pixels in the axial plane and slice thickness of 1.25 mm was adopted to reduce partial volume effects. To determine gross tumor volume (GTV), contrast-enhanced CT and MRI were acquired. Conditions for non-contrast and contrast-enhanced CT were the same except for the size of the field of view. The slice thickness of MRI was specified from 1–2 mm depending on the tumor size by 3D-SPGR (3D fast-spoiled gradient-recalled acquisition in the steady state) sequence with gadolinium enhancement and 3D fast spin echo. All 14 patients underwent treatment-planning CT and MRI. Planning CT and MRI were fused on the iPlan RT Image version 4.1.2 (BrainLAB). Delineation of target and risk organs was performed with an autosegmentation function and manually by a radiation oncologist and a neurosurgeon on iPlan RT image treatment-planning software. The PTV margin was determined to be 2 mm, considering the spatial uncertainty, including the patient setup error, isocenter mechanical deviation, and ExacTrac image-guidance error [6]. When the CTV was in close contact with critical organs, the CTV-PTV margin was adjusted manually to avoid overlapping the PTV and these critical organs. The Novalis equipped with a micro-multileaf collimator (mMLC) with 3-mm thick leaves (m3; BrainLAB) was used. SRS/SRT with the Novalis system has been described previously [2, 3, 5]. The targets were covered with a ≥ 95% isodose level. The PTV ranged from 1.1–102.2 ml (median, 19.5 ml). The algorithm of dose calculation in iPlan RT dose version 4.1.2 software was the pencil beam convolution (PBC) method. Dosing for all patients was planned with a single isocenter IMRT by radiation oncologists and neurosurgeons. Parameter evaluation of the dose–volume histogram (DVH) was performed considering target coverage and the dose limitation for OARs. The dose constraints for OARs used in the IMRT optimization process were determined according to tolerance dose; e.g. 55 Gy for brain stem (0.1 ml-volume), 50 Gy for optic nerve (0.1 ml), 10 Gy for lens (max), 50 Gy for eye (1 ml), and 50 Gy for acoustic nerve (0.1 ml) with a 2 Gy per fraction regime. The patients underwent IM-SRT calculated by PBC with 6-MV photon beams in 14–18 fractions to a total dose of 40–48 Gy (median 42.5 Gy) (at 100% isodose = at normalization point) over 3–4 weeks. The IM-SRT treatment times were estimated for a dose rate of 320 monitor units/min, calculated in log files of patient management software for treatment. The same CT image data and structure sets including PTV and OARs of patients that were used in Novalis treatment were transferred to LGP version 10.1.1 treatment-planning software from iPlan treatment-planning software via a DICOM-RT protocol. We determined a 2-mm PTV margin around the GTV (= CTV, clinical target volume) in multisession GK-SRT using the Extend system. The dose algorithm, available in LGP software is a simple tissue maximum ratio (TMR) 10 method employing the measurement-based dose calculation by replacing all anatomical structures with water-equivalent material [7]. Multi-isocenter beam delivery, different from the Novalis single isocenter technique, was used to cover the target volume. The OARs were spared as much as possible (e.g. optic nerves less than approximately half of the prescribed isodose) even when it was adjacent to the target. The prescribed dose-fractionation schedule for the target was defined as the same as that used in Novalis IM-SRT. The treatment times with GK PFX-SRT were also estimated using a dose rate of 2.722 Gy/min for 60Cobalt, calculated by LGP treatment software. In this study, we evaluated each dosimetric characteristic using dosimetric metrics of both Novalis IM-SRT as LINAC-based SRT and multisession GK PFX-SRT using the Extend system with a relocatable frame system. We used the dose-calculation algorithm of PBC for the Novalis plan and TMR 10 for the GK plan. Collected dosimetry data were analyzed using SPSS version 18.0 (IBM, Japan). The paired t test was used to examine differences between indices of Novalis IM-SRT and those of PFX-SRT treatment plans. Differences with P 0.05 were regarded as significant.
机译:我们采用强度调节立体定向放射疗法(IM-SRT),对14例颅底(n = 5)或海绵窦(n = 4)脑膜瘤,颅咽管瘤(n = 4)或垂体腺瘤(n = 1)的患者进行了治疗。 Novalis于2011年4月至2012年6月。在本研究中,还额外制定了GK PFX治疗计划作为每个患者的模拟计划。比较了使用Novalis的实际治疗计划和GK PFX的模拟计划。使用1.5特斯拉或3.0特斯拉扫描仪(Signa Echo Speed Plus 1.5 T,Signa HDxt 3.0 T; GE Healthcare,东京)和4台计算机断层扫描(CT)通过磁共振成像(MRI)获取治疗计划图像)(Light Speed Plus; GE Healthcare,东京)。治疗计划中剂量计算的参考是CT图像。为了减少局部体积效应,采用了轴向平面上512×512像素的CT图像分辨率和1.25 mm的切片厚度。为了确定总肿瘤体积(GTV),获取了增强对比的CT和MRI。除视场大小外,无对比度和增强对比度的CT的条件相同。根据3D-SPGR(3D快速变质梯度,在稳态下称为采集)序列,并以ado增强和3D快速自旋回波来确定MRI的切片厚度,范围为1-2 mm。所有14例患者均接受了治疗计划的CT和MRI检查。在iPlan RT Image版本4.1.2(BrainLAB)上融合了Planning CT和MRI。使用自动分段功能,并由放射肿瘤学家和神经外科医生在iPlan RT图像治疗计划软件上手动对目标器官和危险器官进行描绘。考虑到空间不确定性,包括患者设置误差,等中心点机械偏差和ExacTrac图像引导误差[6],确定PTV裕度为2 mm。当CTV与关键器官紧密接触时,手动调整CTV-PTV的余量,以避免PTV和这些关键器官重叠。使用配备了微多叶准直仪(mMLC)且具有3毫米厚的叶片(m3; BrainLAB)的Novalis。先前已经描述了使用Novalis系统的SRS / SRT [2、3、5]。靶标的等剂量剂量≥95%。 PTV的范围为1.1-102.2 ml(中位数为19.5 ml)。 iPlan RT剂量版本4.1.2软件中的剂量计算算法是笔形束卷积(PBC)方法。放射肿瘤学家和神经外科医生计划使用单一等中心IMRT为所有患者进行给药。考虑目标覆盖率和OAR的剂量限制,对剂量-体积直方图(DVH)进行参数评估。根据耐受剂量确定IMRT优化过程中使用的OAR的剂量限制;例如脑干55戈瑞(0.1毫升),视神经50戈瑞(0.1毫升),晶状体(最大)10戈瑞,眼睛(1毫升)50戈瑞,声神经(0.1毫升)50戈瑞每分数方案2 Gy。患者在3至4周内接受了14-18分量的6-MV光子束通过PBC计算的IM-SRT,总剂量为40-48 Gy(中位值为42.5 Gy)(100%等剂量=归一化点)。 IM-SRT的治疗时间估计为320监测单位/分钟的剂量率,该剂量率在患者管理软件的日志文件中进行计算。通过DICOM-RT协议从iPlan治疗计划软件将相同的CT图像数据和结构集(包括用于Novalis治疗的患者的PTV和OAR)转移到iPlan治疗计划软件的LGP 10.1.1治疗计划软件中。我们使用Extend系统在多会话GK-SRT中确定了GTV周围2 mm PTV的余量(= CTV,临床目标体积)。 LGP软件中提供的剂量算法是一种简单的组织最大比率(TMR)10方法,该方法通过将所有解剖结构替换为等效水的材料来采用基于测量的剂量计算[7]。与Novalis单等中心技术不同,多等中心光束传输用于覆盖目标体积。即使OAR与靶标相邻,也要尽可能地省去它们(例如视神经少于规定的等剂量的一半)。规定的目标剂量分级时间表与Novalis IM-SRT中使用的相同。还使用LGP处理软件计算的 60 Cobalt剂量率为2.722 Gy / min估计了GK PFX-SRT的治疗时间。在这项研究中,我们使用Novalis IM-SRT作为基于LINAC的SRT和使用Extend系统和可重定位框架系统的多会话GK PFX-SRT的剂量度量,评估了每个剂量特征。对于Novalis计划,我们使用PBC的剂量计算算法;对于GK计划,我们使用TMR 10的剂量计算算法。使用SPSS 18.0版(IBM,日本)分析收集的剂量学数据。配对t检验用于检验Novalis IM-SRT指数与PFX-SRT治疗计划的指数之间的差异。 P <0.05的差异被认为是显着的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号